Asha Moudgil

Summary

Publications

  1. doi request reprint Best allograft survival from share-35 kidney donors occurs in middle-aged adults and young children-an analysis of OPTN data
    Asha Moudgil
    Children National Medical Center, Washington, DC 20010, USA
    Transplantation 95:319-25. 2013
  2. doi request reprint Primer on renal transplantation
    Asha Moudgil
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue, NW Washington, DC 20010, USA
    Indian J Pediatr 79:1076-83. 2012
  3. doi request reprint Good outcome of kidney transplants in recipients of young donors: a NAPRTCS data analysis
    Asha Moudgil
    Nephrology, Children National Medical Center, Washington, DC, USA
    Pediatr Transplant 15:167-71. 2011
  4. doi request reprint Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection
    Kiran Upadhyay
    Department of Nephrology, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Transplant 16:286-93. 2012
  5. doi request reprint Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients
    Douglas M Silverstein
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue NW, Washington, D C 20010, USA
    Pediatr Nephrol 26:1123-8. 2011
  6. doi request reprint Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient
    Parnell Mattison
    Department of Nephrology, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Nephrol 25:971-6. 2010
  7. doi request reprint Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome
    Kristen Sgambat
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue NW, Washington DC, 20010, USA
    Pediatr Nephrol 28:2131-5. 2013
  8. doi request reprint Lipoprotein profile changes in children after renal transplantation in the modern immunosuppression era
    Kristen Sgambat
    Division of Nutrition, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Transplant 12:796-803. 2008
  9. ncbi request reprint Induction therapy in pediatric renal transplant recipients: an overview
    Asha Moudgil
    Department of Nephrology, Children s National Medical Center, Washington, District of Columbia 20010, USA
    Paediatr Drugs 9:323-41. 2007
  10. ncbi request reprint Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient
    Mahima Keswani
    Department of Pediatrics, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA
    Pediatr Transplant 11:568-71. 2007

Collaborators

Detail Information

Publications18

  1. doi request reprint Best allograft survival from share-35 kidney donors occurs in middle-aged adults and young children-an analysis of OPTN data
    Asha Moudgil
    Children National Medical Center, Washington, DC 20010, USA
    Transplantation 95:319-25. 2013
    ..The intent of this study was to analyze the graft outcomes from S35 kidneys in pediatric and adult recipients, stratified further by recipient age, to assess if recipient age affects the outcome from these presumably ideal kidneys...
  2. doi request reprint Primer on renal transplantation
    Asha Moudgil
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue, NW Washington, DC 20010, USA
    Indian J Pediatr 79:1076-83. 2012
    ....
  3. doi request reprint Good outcome of kidney transplants in recipients of young donors: a NAPRTCS data analysis
    Asha Moudgil
    Nephrology, Children National Medical Center, Washington, DC, USA
    Pediatr Transplant 15:167-71. 2011
    ..Although primary graft non-function was higher, eGFR of functioning grafts was comparable to ID. With further improvements in care, kidneys from YD may present a viable option for transplantation...
  4. doi request reprint Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection
    Kiran Upadhyay
    Department of Nephrology, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Transplant 16:286-93. 2012
    ..However, symptomatic viral infections were not observed in any of the children. Treatment with alemtuzumab may prolong allograft survival in multidrug-resistant AR but may not prevent recurrent AR in non-adherent children...
  5. doi request reprint Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients
    Douglas M Silverstein
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue NW, Washington, D C 20010, USA
    Pediatr Nephrol 26:1123-8. 2011
    ..01]. Finally, there was no relationship between serum UA and normalized protein catabolic rate (r = 0.14; p = 0.4). In summary, serum UA impacts BP in pediatric HD patients, independent of volume, nutritional and weight status...
  6. doi request reprint Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient
    Parnell Mattison
    Department of Nephrology, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Nephrol 25:971-6. 2010
    ..For the following 6 months, the patient maintained adequate (>10 g/dL) hemoglobin levels and did not require red cell transfusions...
  7. doi request reprint Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome
    Kristen Sgambat
    Department of Nephrology, Children s National Medical Center, 111 Michigan Avenue NW, Washington DC, 20010, USA
    Pediatr Nephrol 28:2131-5. 2013
    ..Galactose binds and inactivates FSPF in vitro, but its effect in vivo is uncertain...
  8. doi request reprint Lipoprotein profile changes in children after renal transplantation in the modern immunosuppression era
    Kristen Sgambat
    Division of Nutrition, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Transplant 12:796-803. 2008
    ..No side effects of therapy were observed. Although dyslipidemia remains a significant problem in pediatric renal TX recipients in the modern era, the prevalence may have decreased with use of newer IS drugs...
  9. ncbi request reprint Induction therapy in pediatric renal transplant recipients: an overview
    Asha Moudgil
    Department of Nephrology, Children s National Medical Center, Washington, District of Columbia 20010, USA
    Paediatr Drugs 9:323-41. 2007
    ..Newer lymphocyte-depleting agents such as alemtuzumab may be better utilized in minimization regimens involving one or two oral maintenance immunosuppressive agents...
  10. ncbi request reprint Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient
    Mahima Keswani
    Department of Pediatrics, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA
    Pediatr Transplant 11:568-71. 2007
    ....
  11. ncbi request reprint Renal transplantation
    Asha Moudgil
    George Washington University, 3 5 300, West Wing, Department of Nephrology, Children s National Medical Center, Washington, D C 20010, USA
    Indian J Pediatr 70:257-64. 2003
    ..Socio-economic factors should be carefully evaluated before offering transplantation to children in developing countries. Preemptive transplantation from a living donor may be a more viable option for these children...
  12. doi request reprint Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis
    Kristen Sgambat
    Department of Nephrology, Children s National Medical Center, 111 Michigan Ave NW, Washington, DC 20010, USA
    Pediatr Nephrol 27:1381-7. 2012
    ..Carnitine plays a key role in energy production in the myocardium. Carnitine deficiency commonly occurs in patients on chronic hemodialysis (HD) and may contribute to cardiomyopathy...
  13. doi request reprint Low bone mineral density and nutritional vitamin D deficiency in pediatric renal transplant recipients: Assessment of risk factors and response to oral vitamin D therapy
    Kristen Sgambat
    Department of Nephrology, Children s National Medical Center Emergency Medicine, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Transplant 15:790-7. 2011
    ..5% had BMD (z < -1) after height adjustment. AA Tx had 3.4-fold higher risk of low BMD vs. controls (p < 0.05). Low VitD and BMD are prevalent in children after renal Tx. Better repletion of VitD is achieved with cholecalciferol...
  14. doi request reprint Carnitine deficiency in children receiving continuous renal replacement therapy
    Kristen Sgambat
    Department of Nephrology, Children s National Health System, Washington, DC, USA
    Hemodial Int 20:63-7. 2016
    ..Consequences of deficiency and benefits of supplementation in the pediatric CRRT population should be investigated. ..
  15. doi request reprint Late acute rejection: incidence, risk factors, and effect on graft survival and function
    Loai Eid
    Department of Nephrology, Children s National Medical Center, Washington, DC, USA
    Pediatr Transplant 18:155-62. 2014
    ..2 months. Patients with de novo DSA and DGF should be considered at risk of LAR; an early diagnosis and treatment of LAR may improve graft survival and function...
  16. doi request reprint Cinacalcet is efficacious in pediatric dialysis patients
    Douglas M Silverstein
    Children s National Medical Center, Washington, DC, USA
    Pediatr Nephrol 23:1817-22. 2008
    ..6 +/- 2.3 pretreatment vs. 4.3 +/- 1.7 micrograms/day posttreatment pg/ml). We conclude that short-term treatment with the calcimimetic cinacalcet is efficacious in adolescent dialysis patients...
  17. ncbi request reprint Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil
    Asha Moudgil
    Division of Nephrology, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA
    Pediatr Nephrol 21:281-5. 2006
    ..Because of the severe side effects of corticosteroids, mycophenolate mofetil was added and corticosteroids were tapered off. The child has been in sustained remission for over a year with mycophenolate mofetil monotherapy...